Efficacy and safety of insulin degludec given as part of basal–bolus treatment with mealtime insulin aspart in type 1 diabetes: a 26-week randomized, open-label, treat-to-target no...

por Davies, M J, Gross, J L, Ono, Y, Sasaki, T, Bantwal, G, Gall, M A, Niemeyer, M, Seino, H
Publicado 2014